La chaîne d'options affiche les données clés des options sur actions de Janux Therapeutics à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Janux Therapeutics..

Janux Therapeutics (NASDAQ:JANX) Stock, Chaîne d'Options

JANUX THERAPEUTICS INC

Janux Therapeutics

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Janux Therapeutics Inc

Citigroup analyst Paul Lejuez maintains Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) with a Neutral and raises the price target from $95 to $97.

News

Price Target

Analyst Ratings

Citigroup Maintains Neutral on Target, Raises Price Target to $97

DoorDash, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) launched a <a href="https://www.benzinga.com/pressreleases/25/05/b45405406/doordash-expands-drone-delivery-partnership-with-wing-in-charlotte" target="_blank" rel="noreferrer noopener">new era of food delivery</a> in Charlotte, North Carolina, on Wednesday. 
The company partnered with drone logistics company Wing to introduce airborne deliveries to the region. The initiative is now live for select customers near The Arboretum Shopping Center in the southern part of the city.
This collaboration builds on a broader partnership between the two firms that began in 2022 in Australia and has since expanded across the United States.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45244999/dashpass-doubledash-and-drones-doordash-plans-to-connect-every-local-business-to-every-local-consumer" rel="noreferrer noopener">DashPass, DoubleDash And Drones: DoorDash Plans To &#8216;Connect Every Local Business To Every Local Consumer&#8217;</a>
Customers within a four-mile radius of The Arboretum can now opt for drone delivery on orders from participating restaurants, including local favorites and well-known brands such as Curry Junction, Joa Korean food, and Panera Bread.
The drone rollout is spearheaded by DoorDash Labs, the company&#8217;s automation and robotics division.
Along with Wing, DoorDash is experimenting with multi-modal delivery networks that also include sidewalk robots from Coco Robotics.
The broader goal is to improve service efficiency and enhance customer satisfaction while providing new earning avenues for delivery partners.
North Carolina&#8217;s proactive stance on drone technology has made it a natural fit for this latest deployment.
According to Wing CEO Adam Woodworth, Charlotte&#8217;s openness to tech-forward solutions made it an ideal candidate for its newest expansion.
Eligible customers will notice a &#8220;Drone&#8221; option in the DoorDash app. After selecting an eligible item, users can opt for drone delivery at checkout. Once confirmed, live tracking enables them to monitor their order as it flies in.
In addition to food, select DashMart items &#8211; such as snacks, drinks, and over-the-counter medications &#8211; are also available for drone delivery.
Price Action: DASH shares are trading higher by 0.24% to $198.28 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45406180/only-half-of-sp-500-stocks-joined-the-tariff-relief-rally-time-to-buy-the-laggards" target="_blank" rel="noreferrer noopener">Only Half Of S&amp;P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards?</a></li>
</ul>
Image via Shutterstock

Equities

Markets

Movers

Tech

General

DASH

What's Going On With DoorDash Stock On Wednesday?

Maxim Group analyst Tate Sullivan maintains Caledonia Mining (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CMCL#AMEX">CMCL</a>) with a Buy and raises the price target from $18 to $21.

CMCL

Maxim Group Maintains Buy on Caledonia Mining, Raises Price Target to $21

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$200.00</td>
<td>$605.0K</td>
<td>1.6K</td>
<td align="right">551</td>
</tr>
<tr>
<td>RKLB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$27.00</td>
<td>$26.3K</td>
<td>2.8K</td>
<td align="right">423</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$85.00</td>
<td>$80.4K</td>
<td>8.2K</td>
<td align="right">404</td>
</tr>
<tr>
<td>UPS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$95.00</td>
<td>$56.6K</td>
<td>1.1K</td>
<td align="right">284</td>
</tr>
<tr>
<td>FDX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$250.00</td>
<td>$25.0K</td>
<td>1.2K</td>
<td align="right">133</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$330.00</td>
<td>$86.8K</td>
<td>225</td>
<td align="right">81</td>
</tr>
<tr>
<td>POWL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$185.00</td>
<td>$172.5K</td>
<td>23</td>
<td align="right">75</td>
</tr>
<tr>
<td>DE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$500.00</td>
<td>$31.3K</td>
<td>465</td>
<td align="right">44</td>
</tr>
<tr>
<td>PAYC</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$230.00</td>
<td>$35.3K</td>
<td>20</td>
<td align="right">5</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding GE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), we observe a put option trade with bullish sentiment. It expires in 247 day(s) on January 16, 2026. Parties traded 550 contract(s) at a $200.00 strike. The total cost received by the writing party (or parties) was $605.0K, with a price of $1100.0 per contract. There were 1609 open contracts at this strike prior to today, and today 551 contract(s) were bought and sold. 
• For RKLB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>), we notice a call option sweep that happens to be bearish, expiring in 65 day(s) on July 18, 2025. This event was a transfer of 135 contract(s) at a $27.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $26.3K, with a price of $195.0 per contract. There were 2855 open contracts at this strike prior to today, and today 423 contract(s) were bought and sold. 
• For UBER (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), we notice a call option trade that happens to be bullish, expiring in 2 day(s) on May 16, 2025. This event was a transfer of 145 contract(s) at a $85.00 strike. The total cost received by the writing party (or parties) was $80.4K, with a price of $555.0 per contract. There were 8227 open contracts at this strike prior to today, and today 404 contract(s) were bought and sold. 
• For UPS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>), we notice a call option trade that happens to be bullish, expiring in 247 day(s) on January 16, 2026. This event was a transfer of 51 contract(s) at a $95.00 strike. The total cost received by the writing party (or parties) was $56.6K, with a price of $1110.0 per contract. There were 1115 open contracts at this strike prior to today, and today 284 contract(s) were bought and sold. 
• Regarding FDX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>), we observe a call option sweep with bullish sentiment. It expires in 65 day(s) on July 18, 2025. Parties traded 40 contract(s) at a $250.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $25.0K, with a price of $625.0 per contract. There were 1206 open contracts at this strike prior to today, and today 133 contract(s) were bought and sold. 
• Regarding CAT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>), we observe a call option sweep with bearish sentiment. It expires in 93 day(s) on August 15, 2025. Parties traded 26 contract(s) at a $330.00 strike. This particular call needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $86.8K, with a price of $3340.0 per contract. There were 225 open contracts at this strike prior to today, and today 81 contract(s) were bought and sold. 
• Regarding POWL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>), we observe a put option trade with bearish sentiment. It expires in 93 day(s) on August 15, 2025. Parties traded 75 contract(s) at a $185.00 strike. The total cost received by the writing party (or parties) was $172.5K, with a price of $2300.0 per contract. There were 23 open contracts at this strike prior to today, and today 75 contract(s) were bought and sold. 
• Regarding DE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), we observe a put option trade with bullish sentiment. It expires in 37 day(s) on June 20, 2025. Parties traded 16 contract(s) at a $500.00 strike. The total cost received by the writing party (or parties) was $31.3K, with a price of $1960.0 per contract. There were 465 open contracts at this strike prior to today, and today 44 contract(s) were bought and sold. 
• Regarding PAYC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>), we observe a call option trade with neutral sentiment. It expires in 611 day(s) on January 15, 2027. Parties traded 5 contract(s) at a $230.00 strike. The total cost received by the writing party (or parties) was $35.3K, with a price of $7073.0 per contract. There were 20 open contracts at this strike prior to today, and today 5 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

PAYC

POWL

RKLB

UBER

9 Industrials Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$350.00</td>
<td>$36.5K</td>
<td>39.2K</td>
<td>144.6K</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$180.00</td>
<td>$60.6K</td>
<td>1.8K</td>
<td>3.6K</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$55.00</td>
<td>$60.7K</td>
<td>4.5K</td>
<td>1.9K</td>
</tr>
<tr>
<td>W</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$40.00</td>
<td>$195.9K</td>
<td>2.6K</td>
<td>1.4K</td>
</tr>
<tr>
<td>MCD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$325.00</td>
<td>$96.1K</td>
<td>665</td>
<td>524</td>
</tr>
<tr>
<td>GCT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$12.50</td>
<td>$62.8K</td>
<td>1.1K</td>
<td>500</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$70.00</td>
<td>$162.8K</td>
<td>344</td>
<td>225</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$115.00</td>
<td>$53.9K</td>
<td>100</td>
<td>172</td>
</tr>
<tr>
<td>WYNN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/18/26</td>
<td>$80.00</td>
<td>$37.3K</td>
<td>903</td>
<td>100</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we notice a call option sweep that happens to be bearish, expiring in 2 day(s) on May 16, 2025. This event was a transfer of 64 contract(s) at a $350.00 strike. This particular call needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $36.5K, with a price of $570.0 per contract. There were 39271 open contracts at this strike prior to today, and today 144665 contract(s) were bought and sold. 
• Regarding BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we observe a call option sweep with bearish sentiment. It expires in 93 day(s) on August 15, 2025. Parties traded 328 contract(s) at a $180.00 strike. This particular call needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $60.6K, with a price of $184.0 per contract. There were 1880 open contracts at this strike prior to today, and today 3689 contract(s) were bought and sold. 
• For CMG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), we notice a put option sweep that happens to be bearish, expiring in 65 day(s) on July 18, 2025. This event was a transfer of 150 contract(s) at a $55.00 strike. This particular put needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $60.7K, with a price of $405.0 per contract. There were 4545 open contracts at this strike prior to today, and today 1909 contract(s) were bought and sold. 
• For W (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>), we notice a put option trade that happens to be bullish, expiring in 2 day(s) on May 16, 2025. This event was a transfer of 1400 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $195.9K, with a price of $140.0 per contract. There were 2602 open contracts at this strike prior to today, and today 1486 contract(s) were bought and sold. 
• For MCD (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), we notice a put option sweep that happens to be bullish, expiring in 65 day(s) on July 18, 2025. This event was a transfer of 46 contract(s) at a $325.00 strike. This particular put needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $96.1K, with a price of $2090.0 per contract. There were 665 open contracts at this strike prior to today, and today 524 contract(s) were bought and sold. 
• Regarding GCT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>), we observe a call option sweep with neutral sentiment. It expires in 2 day(s) on May 16, 2025. Parties traded 100 contract(s) at a $12.50 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $62.8K, with a price of $615.0 per contract. There were 1122 open contracts at this strike prior to today, and today 500 contract(s) were bought and sold. 
• For DHI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>), we notice a call option trade that happens to be bullish, expiring in 2 day(s) on May 16, 2025. This event was a transfer of 30 contract(s) at a $70.00 strike. The total cost received by the writing party (or parties) was $162.8K, with a price of $5429.0 per contract. There were 344 open contracts at this strike prior to today, and today 225 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a call option trade with bullish sentiment. It expires in 611 day(s) on January 15, 2027. Parties traded 5 contract(s) at a $115.00 strike. The total cost received by the writing party (or parties) was $53.9K, with a price of $10792.0 per contract. There were 100 open contracts at this strike prior to today, and today 172 contract(s) were bought and sold. 
• Regarding WYNN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>), we observe a call option sweep with neutral sentiment. It expires in 583 day(s) on December 18, 2026. Parties traded 13 contract(s) at a $80.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $37.3K, with a price of $2875.0 per contract. There were 903 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

BABA

TSLA

WYNN

9 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Information Technology sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$135.00</td>
<td>$39.1K</td>
<td>88.0K</td>
<td>231.9K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$215.00</td>
<td>$53.0K</td>
<td>25.0K</td>
<td>112.0K</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$400.00</td>
<td>$51.0K</td>
<td>15.2K</td>
<td>64.1K</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$130.00</td>
<td>$63.2K</td>
<td>21.4K</td>
<td>24.2K</td>
</tr>
<tr>
<td>SMCI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$44.00</td>
<td>$54.2K</td>
<td>2.3K</td>
<td>10.8K</td>
</tr>
<tr>
<td>SOUN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$13.00</td>
<td>$53.5K</td>
<td>4.7K</td>
<td>7.1K</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/23/25</td>
<td>$240.00</td>
<td>$35.0K</td>
<td>1.9K</td>
<td>5.6K</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$380.00</td>
<td>$386.4K</td>
<td>3.1K</td>
<td>1.2K</td>
</tr>
<tr>
<td>PATH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$13.00</td>
<td>$112.2K</td>
<td>5.1K</td>
<td>662</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$40.00</td>
<td>$52.3K</td>
<td>3.0K</td>
<td>450</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on May 16, 2025. Parties traded 237 contract(s) at a $135.00 strike. This particular call needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $39.1K, with a price of $165.0 per contract. There were 88096 open contracts at this strike prior to today, and today 231993 contract(s) were bought and sold. 
• For AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we notice a call option sweep that happens to be bearish, expiring in 2 day(s) on May 16, 2025. This event was a transfer of 663 contract(s) at a $215.00 strike. This particular call needed to be split into 12 different trades to become filled. The total cost received by the writing party (or parties) was $53.0K, with a price of $79.0 per contract. There were 25003 open contracts at this strike prior to today, and today 112029 contract(s) were bought and sold. 
• Regarding MSFT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), we observe a call option trade with bearish sentiment. It expires in 2 day(s) on May 16, 2025. Parties traded 10 contract(s) at a $400.00 strike. The total cost received by the writing party (or parties) was $51.0K, with a price of $5100.0 per contract. There were 15204 open contracts at this strike prior to today, and today 64139 contract(s) were bought and sold. 
• Regarding PLTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on May 16, 2025. Parties traded 250 contract(s) at a $130.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $63.2K, with a price of $253.0 per contract. There were 21488 open contracts at this strike prior to today, and today 24224 contract(s) were bought and sold. 
• For SMCI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), we notice a put option sweep that happens to be bearish, expiring in 2 day(s) on May 16, 2025. This event was a transfer of 321 contract(s) at a $44.00 strike. This particular put needed to be split into 16 different trades to become filled. The total cost received by the writing party (or parties) was $54.2K, with a price of $169.0 per contract. There were 2304 open contracts at this strike prior to today, and today 10838 contract(s) were bought and sold. 
• For SOUN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>), we notice a call option sweep that happens to be bearish, expiring in 37 day(s) on June 20, 2025. This event was a transfer of 500 contract(s) at a $13.00 strike. This particular call needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $53.5K, with a price of $107.0 per contract. There were 4712 open contracts at this strike prior to today, and today 7197 contract(s) were bought and sold. 
• Regarding AVGO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), we observe a call option sweep with neutral sentiment. It expires in 9 day(s) on May 23, 2025. Parties traded 100 contract(s) at a $240.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $35.0K, with a price of $350.0 per contract. There were 1944 open contracts at this strike prior to today, and today 5640 contract(s) were bought and sold. 
• Regarding MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we observe a call option trade with bullish sentiment. It expires in 400 day(s) on June 18, 2026. Parties traded 24 contract(s) at a $380.00 strike. The total cost received by the writing party (or parties) was $386.4K, with a price of $16100.0 per contract. There were 3149 open contracts at this strike prior to today, and today 1261 contract(s) were bought and sold. 
• Regarding PATH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), we observe a call option trade with bullish sentiment. It expires in 128 day(s) on September 19, 2025. Parties traded 600 contract(s) at a $13.00 strike. The total cost received by the writing party (or parties) was $112.2K, with a price of $187.0 per contract. There were 5110 open contracts at this strike prior to today, and today 662 contract(s) were bought and sold. 
• Regarding ENPH (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>), we observe a put option sweep with bearish sentiment. It expires in 128 day(s) on September 19, 2025. Parties traded 136 contract(s) at a $40.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $52.3K, with a price of $385.0 per contract. There were 3073 open contracts at this strike prior to today, and today 450 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

AVGO

ENPH

MSFT

MSTR

NVDA

PATH

PLTR

SMCI

SOUN

10 Information Technology Stocks Whale Activity In Today's Session

Maxim Group analyst Michael Diana maintains PennantPark Floating Rate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFLT#NYSE">PFLT</a>) with a Buy and lowers the price target from $12.5 to $11.5.

PFLT

Maxim Group Maintains Buy on PennantPark Floating Rate, Lowers Price Target to $11.5

Maxim Group analyst Jack Vander Aarde maintains VerifyMe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRME#NASDAQ">VRME</a>) with a Buy and lowers the price target from $2 to $1.5.

VRME

Maxim Group Maintains Buy on VerifyMe, Lowers Price Target to $1.5

Biodesix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) reported weaker-than-expected results for the first <a href="https://www.benzinga.com/quote/BDSX/earnings">quarter on Tuesday</a>.
The company posted quarterly losses of 8 cents per share which missed the analyst consensus estimate of losses of 7 cents per share. The company reported quarterly sales of $17.96 million which missed the analyst consensus estimate of $19.47 million.
&#8220;Our quarter was highlighted by continued progress toward our three key goals for 2025 – growing top line revenue, improving operational efficiencies and leverage, and advancing our pipeline,&#8221; said Scott Hutton, Chief Executive Officer. &#8220;Year-over-year, we grew revenue by 21%, powered by growth in both our lung diagnostic testing and diagnostic services, all while decreasing our SG&amp;A spend. Lung Diagnostics revenue grew 18%, which is the 16th straight quarter of greater than 15% growth. We also increased our already strong gross margins to 79.4%, improved Net Loss by 18% and Adjusted EBITDA by 11% on our path to profitability, and presented multiple studies on our pipeline products to help facilitate future growth.&#8221;
Biodesix lowered its FY2025 sales guidance from $92.00 million-$95.00 million to $80.00 million-$85.00 million.
Biodesix shares fell 39.3% to trade at $0.2180 on Wednesday.
These analysts made changes to their price targets on Biodesix following earnings announcement.
<ul class="wp-block-list">
<li>Lake Street analyst Thomas Flaten maintained Biodesix with a Buy and lowered the price target from $3 to $2.</li>
<li>Canaccord Genuity analyst Kyle Mikson maintained the stock with a Buy and lowered the price target from $2.5 to $1.5.</li>
<li>William Blair analyst Brian Weinstein downgraded Biodesix from Outperform to Market Perform.</li>
</ul>
Considering buying BDSX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14133022/image-168-1024x576.png" alt="" class="wp-image-915425" style="width:660px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14133022/image-168-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14133022/image-168-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14133022/image-168-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14133022/image-168.png 1080w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45403847/coinbase-to-rally-around-17-here-are-10-top-analyst-forecasts-for-wednesday">Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday</a> </li>
</ul>
Photo via Shutterstock

Earnings

BDSX

Biodesix Analysts Lower Their Forecasts After Downbeat Q1 Results

Roth MKM analyst Sean McGowan maintains Monster Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>) with a Neutral and raises the price target from $50 to $56.

MNST

Roth MKM Maintains Neutral on Monster Beverage, Raises Price Target to $56

WIIM

ABSI

ABSI stock has given up its prior gain. Absci shares were trading higher after the company announced it began dosing the first participants in its Phase 1 ABS-101 clinical trial.

Although talk of a recession has some investors spooked, stock market veterans like CNBC's Jim Cramer see it as an opportunity to pick up undervalued stocks. On a recent episode of<a href="https://www.cnbc.com/2025/03/13/jim-cramer-names-retail-stocks-to-buy-as-the-market-pulls-back.html"> "Mad Money</a>," Cramer discussed the economy and two stocks he believes are worth buying during any potential dip.
&nbsp;"As long as you don't think the entire economy is about to fall off a cliff, and there's still some of us who feel that way, then some of these high-quality retailers are looking darned cheap at these levels," he said. "Ralph Lauren [(NYSE:<a href="https://www.benzinga.com/quote/RL"> RL</a>)] and the Gap [(NYSE:<a href="https://www.benzinga.com/quote/GAP/news"> GAP</a>)] are my faves right now." That may be surprising, considering that Cramer said the<a href="https://www.benzinga.com/content/44299286/3-retail-giants-react-to-tariffs-what-it-means-for-consumers"> retail sector</a> was in the "blast radius" of a trade war.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
</ul>
There may be a method to Cramer's madness. He acknowledged that the immediate effect of tariffs would be to drive prices up and slow consumer activity. That's normal anytime there is a sudden price increase for products that people have grown accustomed to getting for less. However, Cramer doesn't think the slowdown will last forever.
He said that the "tariff reign of terror is temporary," meaning consumers will either become accustomed to the elevated prices or that a settlement will be reached between President Trump and the countries he's targeted for tariffs. In either case, the retail sector would rebound, and any stocks that took a hit during the recession would also make a comeback.
Cramer explained his reasons for picking Gap and Ralph Lauren as potential buys during the downturn. He cited Gap's recent strong quarterly earnings report as evidence that the turnaround led by new CEO Richard Dickson is working. Cramer wasn't the only person impressed by Gap's performance. According to<a href="https://www.cnbc.com/2025/03/06/gap-ceo-unpacks-blowout-quarter-the-progress-is-real.html"> CNBC</a>, the company's stock jumped by 17% in overnight trading after the company's March<a href="https://www.benzinga.com/quote/GAP/earnings"> earnings release</a>.
Trending: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
The report shows Gap exceeded analysts' earnings per share expectations by 42% and outpaces revenue expectation by 1.94% with a $4.15 billion quarter. Dickson said Gap's supply chain will only be minimally affected by Trump's tariffs because it sources less than 10% of its products from China and less than 1% from Mexico and Canada, the three nations that Trump's retail tariffs are currently targeting. Gap is also paying a 3.09% dividend.
Cramer's other retail pick, Ralph Lauren, is also coming off a strong quarterly<a href="https://www.benzinga.com/quote/RL/earnings"> earnings report</a>. The company's $4.82 earnings per share beat expectations by 6.40%, and its $2.14 billion in revenue bested the analysts' predictions by 6.67%. However, Cramer sees other factors playing in Ralph Lauren's favor. He believes the company's history as an upmarket brand and a symbol of high living will give it additional staying power.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Both factors translate into a wealthier client base than many other retailers, and consumers in that economic strata will be less deterred by a temporary price increase. That's why Cramer thinks Ralph Lauren will be among the companies at the leading edge of the rebound once retail bounces back. It doesn't hurt that<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44378283/ralph-laurens-prospects-of-market-share-gains-margin-expansion-turns-this-analyst-bullish"> Ralph Lauren shareholders</a> can earn a 1.44% dividend on the company&#8217;s $225.16 share price while waiting for the turnaround.
Cramer did add one big caveat to his bullish predictions on both stocks. He admitted he doesn't know how long you might have to hold them before the turnaround starts. "If you buy them and the president basically assures you that the forecast is pain, there's not much you can do short term. But longer term, you will do fine – I just can't predict when longer term starts," he said.&nbsp;
Read Next:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Jim Cramer Says These Retail Stocks RL, GAP Can Survive A Market Correction

HC Wainwright &amp; Co. analyst Robert Burns maintains ArriVent BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVBP#NASDAQ">AVBP</a>) with a Buy and raises the price target from $39 to $40.

AVBP

HC Wainwright & Co. Maintains Buy on ArriVent BioPharma, Raises Price Target to $40

Gold is trading lower in possible reaction to US-China trade progress, which could ease macro concerns.

Maxim Group analyst Jason McCarthy downgrades Cellectar Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) from Buy to Hold.

Downgrades

CLRB

Maxim Group Downgrades Cellectar Biosciences to Hold

Roth MKM analyst Suji Desilva maintains Pixelworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXLW#NASDAQ">PXLW</a>) with a Buy and lowers the price target from $2 to $1.

PXLW

Roth MKM Maintains Buy on Pixelworks, Lowers Price Target to $1

Bluebird Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) shares are trading higher on Wednesday following the news that Bluebird Bio, Carlyle, and SK Capital Partners, LP, have amended their definitive agreement.
Under the terms of the amended agreement, Bluebird stockholders can elect to receive either the original offer of $3.00 per share in cash plus a contingent value right (CVR) of $6.84 per share in cash payable upon achievement of a net sales milestone or <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45404624/carlyle-sk-capital-partners-and-bluebird-bio-amend-merger-agreement" rel="noreferrer noopener">$5.00 per share in cash</a>.
The amended offer price provides an alternative for stockholders who would prefer greater upfront cash consideration instead of the potential <a target="_blank" href="https://www.benzinga.com/25/02/43880289/bluebird-bio-to-be-acquired-by-carlyle-group-sk-capital-former-mirati-therapeutics-ceo-set-to-lead-post-deal" rel="noreferrer noopener">upside of the CVR</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/04/44651650/deal-dispatch-us-ma-is-quiet-but-abroad-volume-is-spiking" rel="noreferrer noopener">Deal Dispatch: US M&amp;A Is Quiet, But Abroad? Volume Is Spiking</a>
Any shares tendered for which no election is made will receive the original consideration of $3.00 per share in cash and a contingent value right per share.
In May, Carlyle and SK Capital received all required regulatory approvals to complete the transaction, and all parties expect the transaction to be consummated promptly following the successful completion of the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45206000/carlyle-and-sk-capital-receive-all-required-regulatory-approvals-to-complete-the-acquisition-of-bl" rel="noreferrer noopener">ongoing tender offer</a>.
In March, Bluebird received an unsolicited, non-binding written proposal from Ayrmid Ltd. Ayrmid proposed to acquire Bluebird for an upfront cash payment of $4.50 per share and a one-time contingent value right of $6.84 per share payable upon achieving a&nbsp;<a target="_blank" href="https://www.benzinga.com/25/03/44564776/gene-therapy-focused-bluebird-bio-receives-rival-takeover-offer-stock-jumps" rel="noreferrer noopener">net sales milestone</a>.
In April, the company said that after three weeks of engagement, including a timeline extension, Ayrmid did not submit a binding proposal to acquire Bluebird and had not obtained the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44835630/bluebird-bio-confirms-that-ayrmid-ltd-has-not-delivered-a-binding-offer-or-obtained-necessary-fina" rel="noreferrer noopener">necessary financing</a>.
Price Action: BLUE stock is up 50.3% to $4.98 at the last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/large-cap/25/05/45409509/samsungs-1-7-billion-cooling-spree-buys-flaktgroup-to-target-data-center-boom" target="_blank" rel="noreferrer noopener">Samsung&#8217;s $1.7 Billion Cooling Spree &#8211; Buys FläktGroup To Target Data Center Boom</a></li>
</ul>
Image by Gumbariya via Shutterstock

Biotech

Health Care

BLUE

Bluebird Bio Shareholders Get New All-Cash Offer From Private Equity

Roth Capital analyst Taz Koujalgi reiterates CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) with a Buy and maintains $415 price target.

Reiteration

CYBR

Roth Capital Reiterates Buy on CyberArk Software, Maintains $415 Price Target

Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45372571/anthony-scaramucci-says-bitcoin-is-evolving-from-a-tech-asset-to-digital-gold">extreme volatility</a> makes it unsuitable as a benchmark for liquid funds, according to a new report from RedStone Oracles.
What Happened: Authored by Marcin Kaźmierczak, the report argues that while Bitcoin has delivered headline-grabbing returns, its risk-adjusted performance disqualifies it as a standard for measuring the success of capital preservation strategies.
The analysis shows that Bitcoin's Sharpe ratio ranged from -6.58 to 6.97, and 25% of observations fell below -1.20, metrics that signal high capital risk and inconsistency.
These traits contradict the core objectives of liquid funds, which prioritize stability, capital efficiency and liquidity.
&#8220;Volatility, risk appetite, and investment horizons reveal why benchmarking every fund to the Bitcoin performance is fundamentally flawed,&#8221; Kaźmierczak wrote, noting that return rates alone offer a dangerously incomplete picture.
Even when compared to growth-oriented traditional indices like the S&amp;P 500, which itself may be too volatile for many liquid fund mandates, Bitcoin underperforms in terms of stability. 
The report notes that Bitcoin saw a -49.22% drawdown between January and September 2024, while the S&amp;P 500&#8217;s largest decline during the same period was -15.59%.
The standard deviation of Bitcoin's Sharpe ratio, calculated at 2.72, highlights frequent oscillations between extreme gains and severe losses.
These sharp swings, the report argues, expose portfolios to unacceptable downside risk, especially for funds with short-term liquidity requirements.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45409339/jpmorgan-completes-first-public-trade-of-tokenized-treasuries">JPMorgan Completes First Public Trade Of Tokenized Treasuries</a>
Why It Matters: Kaźmierczak also emphasizes the difference in performance evaluation frameworks now emerging in on-chain finance.
Platforms like Morpho and Euler are enabling fund managers to structure "vaults" that optimize for liquidity, yield, and risk.
While returns from these platforms may trail simple BTC holding strategies, they represent a more sustainable approach by adopting professional-grade risk frameworks.
By using 30-day rolling Sharpe ratios and controlling for trading days, the report builds a time-synchronized performance model, underscoring the need to consider risk-adjusted returns rather than chasing linear growth metrics.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45405649/the-curious-story-behind-the-melania-trump-meme-coin-launch">The Curious Story Behind The Melania Trump Meme Coin Launch</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin's Volatility Makes It Unfit As A Benchmark For Liquid Funds: Report

Ladenburg Thalmann analyst Mickey Schleien downgrades Gladstone Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAIN#NASDAQ">GAIN</a>) from Buy to Neutral.

GAIN

Ladenburg Thalmann Downgrades Gladstone Inv to Neutral

Press Releases

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC

Janux Therapeutics Announces Proposed Public Offering

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters' Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

Clear Street Launches Healthcare & Biotechnology Equity Research

Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer

Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates

Janux Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights

Comments

Janux Therapeutics

Janux Therapeutics (JANX) Options

Loading...

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL